Technical Analysis for ACRS - Aclaris Therapeutics, Inc.

Grade Last Price % Change Price Change
D 1.25 4.62% 0.06
ACRS closed down 1.65 percent on Friday, February 23, 2024, on 33 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 4.62%
Bollinger Band Squeeze Range Contraction 4.62%
20 DMA Support Bullish 2.89%
Bollinger Band Squeeze Range Contraction 2.89%
Earnings Movers Other 2.89%
20 DMA Support Bullish 3.75%
Bollinger Band Squeeze Range Contraction 3.75%
Earnings Movers Other 3.75%
Crossed Above 20 DMA Bullish 2.89%
Bollinger Band Squeeze Range Contraction 2.89%

   Recent Intraday Alerts

Alert Time
Gap Up Partially Closed 9 minutes ago
Up 5% 9 minutes ago
Gapped Up (Partial) 13 minutes ago
Rose Above 20 DMA 13 minutes ago
10 DMA Support 13 minutes ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis

Is ACRS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.93
52 Week Low 0.5902
Average Volume 2,165,680
200-Day Moving Average 5.55
50-Day Moving Average 1.13
20-Day Moving Average 1.19
10-Day Moving Average 1.21
Average True Range 0.09
RSI (14) 48.98
ADX 8.64
+DI 18.55
-DI 21.58
Chandelier Exit (Long, 3 ATRs) 1.03
Chandelier Exit (Short, 3 ATRs) 1.33
Upper Bollinger Bands 1.27
Lower Bollinger Band 1.11
Percent B (%b) 0.49
BandWidth 13.49
MACD Line 0.00
MACD Signal Line -0.01
MACD Histogram 0.005
Fundamentals Value
Market Cap 84.3 Million
Num Shares 70.8 Million
EPS -1.66
Price-to-Earnings (P/E) Ratio -0.72
Price-to-Sales 4.00
Price-to-Book 0.56
PEG Ratio -0.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.30
Resistance 3 (R3) 1.30 1.27 1.28
Resistance 2 (R2) 1.27 1.24 1.27 1.27
Resistance 1 (R1) 1.23 1.23 1.23 1.23 1.27
Pivot Point 1.20 1.20 1.20 1.20 1.20
Support 1 (S1) 1.16 1.17 1.16 1.16 1.11
Support 2 (S2) 1.13 1.16 1.13 1.11
Support 3 (S3) 1.09 1.13 1.10
Support 4 (S4) 1.09